Cryptococcus neoformans is an important fungal pathogen, causing life-36 threatening pneumonia and meningoencephalitis. Brain dissemination of C. neoformans 37 is thought to be a consequence of an active infection in the lung which then 38 extravasates to other sites. Brain invasion results from dissemination via the 39 bloodstream, either by free yeast cells in bloodstream or Trojan horse transport within 40 mononuclear phagocytes. We assessed brain dissemination in three mouse models of 41 infection: intravenous, intratracheal, and intranasal. All three modes of infection resulted 42
Introduction: 66
The genus Cryptococcus is populated by environmental fungi, wood-rotting fungi 67 most commonly associated with trees but also with bird guano. Two species of 68
Cryptococcus can cause life-threatening disease in humans, characterized mainly by 69 pneumonia and life-threatening meningoenchephalitis. C. neoformans var. grubii is the 70 most prevalent pathogen of the genus Cryptococcus, causing approximately 200,000 71
deaths each year, mostly associated with HIV-positive individuals, while the closely 72 related species C. gattii was responsible for an outbreak in British Columbia in 73 apparently immunocompetent individuals (1-3). 74
The current paradigm for the pathogenesis of human cryptococcosis emerged 75 from a series of observations made over several decades. Exposure is due to inhalation 76 of infectious propagules from the environmental niches. Colonization of the lungs by 77 spores, desiccated yeasts or yeast cells is thought to be quickly controlled by the 78 human immune system via granuloma formation (called cryptococcoma). In the 1950s, 79 silent cryptococcal granulomas were reported in lungs, establishing a parallel to latent 80 tuberculosis (4). In support of this notion, serological studies have established that 81 adults have antibodies to C. neoformans (5) or had delayed hypersensitivity skin 82 reactions (6), consistent with asymptomatic infection. Both teenagers or children under 83 the age of 5 living in urban areas are immunoreactive against Cryptococcus (7, 8) . 84
Finally HIV-patients are infected with a serotype most commonly isolated from their 85 place of birth or where they spent their infancy (9). Hence, humans are exposed very 86 early in life to this yeast without developing noticeable disease. Silent or latent infections 87 due to containment in the lungs is further supported by the observation that some 88 recipients of lung transplants develop a cryptococcal infection originated from the donor 89 lung (10-12). Even though most infections of C. neoformans in humans are 90 asymptomatic, a significant and unknown proportion of humans become latent carriers 91 of C. neoformans which may reactivate as host immunity declines. 92
Given that initial human infection is thought to start from the lungs, research in 93 pathogenesis of C. neoformans commonly uses pulmonary infection models. The two 94 inoculation routes most commonly used are intratracheal and intranasal infection. 95
Intratracheal infection delivers C. neoformans directly to the respiratory tree but requires 96 surgery and significant skill. In contrast, intranasal infection is done by depositing a 97 solution containing C. neoformans in the nose of an anesthetized mice, which then 98 inhales it as these animals are obligate nose breathers. Since intranasal infection does 99 not require surgery, it has become a popular mode of inducing C. neoformans infection 100 in mice. Intranasal infection has been accepted as a procedure for inducing pulmonary 101 infection without much investigation as to what actually happens after nose deposition 102 of an infective inoculum. In some cases researchers use a third route of infection, the 103 intravenous route, since it allows a rapid dissemination to the brain, presumably by 104 bypassing lung immune response (13, 14) . Intravenous model in outbred mice have 105 been shown to be a relevant model when compared to human infection (15-17). 106
In this study we compared intravenous, intratracheal and intranasal infection and 107 observed that all produce rapid brain dissemination. Additionally, we detected that 108 intranasal inoculation leads to presence of yeasts in upper respiratory airways and 109 auditory tract. These observations have important implications for the interpretation of 110 intranasal studies when considering immune responses and aspects of pathogenesis. 111 112 Materials and Methods: 113 C. neoformans was grown from frozen glycerol stocks into a Yeast Peptone 114 Dextrose (YPD) plate for 2 days, and then cultured overnight at 30 o C in YPD broth with 115
shaking. We used a strain from H99E lineage (available from Lodge laboratory), the H99O 116 strain, a close relative of the original isolate of H99 (18), and the R265 strain of C. gattii, 117 obtained from American Type Culture Collection. 118 C57BL/6J mice, aged 8-10 weeks, were obtained from Jackson Laboratories and 119 infected with the indicated 5x10 3 (low dose) to 5x10 5 CFU (high dose) in a final volume of 120 xylazine-ketamine anesthesia. Animal's neck was exposed, the trachea was exposed via 125 midline incision and yeasts inoculated with a 25G gauge syringe directly into the trachea. 126
Incision was closed with Vetbond (3M, St. Paul, MN, USA). Mice were monitored daily for 127 signs of stress and deterioration of health throughout the experiment. All animal 128 experiments were approved by Johns Hopkins University IACUC under protocol number 129
MO18H152. 130
To measure fungal burden, mice were euthanized, exsanguinated via terminal 131 retroorbital bleeding, tissues removed and macerated by passing through a 100 μm mesh 132 into sterile PBS. The tissue homogenate was then plated into YPD agar plates, and colony 133 forming units (CFU) were quantified. For one experiment we rinsed the brains (to remove 134 possible yeast contaminations from the exterior surface of the brain during necropsy). In 135 one experiment we included a non-infected mouse ("sentinel") to test for accidental 136 contamination of tools and materials during necropsy. 137
For histological analysis of the skull, the skin, lower jaw and tongue were removed 138 and remainder of skull was fixed in Formacal and processed for routine histology. A 139 sagittal cut was performed through the middle section of the mouse skull and 140 consecutives 4 μm sections, with 40 μm intervals were cut for Hematoxylin-Eosin, 141
Mucicarmine, Grocott-Methenamine Silver and immunofluorescence.
For 142 immunofluorescence 18B7 monoclonal antibody against capsular polysaccharides (21) 143 was used and then detected with anti-mouse IgG1-Alexa 488 conjugate antibody. 144
Hematoxylin & eosin sections were scanned using a slide scanner at the Oncology Tissue 145
Services Core (School of Medicine, Johns Hopkins University). Remaining sections were 146 imaged using an Olympus AX70 microscope (Olympus America, NY, USA). Image 147 cropping and annotation were performed using ImageJ (22). 148
Results: 149
We compared 3 routes of infection (IV, IN, and IT) to ascertain the kinetics of C. 150 neoformans dissemination to the brain (Fig.1) . We had previously verified the infectious 151 dose of 5x10 5 CFU induces 100% mortality in 22 days for H99E. We quantified fungal 152 burden in blood, lung and brains. In two mice, we detected fungi in blood although in 153 these we also detected bacteria in blood (data not shown). This suggests that animals 154 with C. neoformans in the blood had severe systemic infection that may have 155 predisposed to concomitant bacterial infection. We conclude that the majority of animals 156 clear C. neoformans from the bloodstream. After 7 days of infection, we measured 157 increased numbers of yeast cells in the brain after IV inoculation (more than 10 5 , upper 158 limit of detection) than after IN or IT inoculation (below 10 4 CFU). In the lung there was a 159 slight increase in fungal burden when the IT route is used, as compared to the IV route. 160
We did not detect differences in brain fungal burden between IN and IT inoculation. 161
Remarkably, we noted there was a substantial amount of yeast in mouse brains as early 162 as day 3 after inoculation of yeast by both IN or IT, which prompted us to ask how 163 quickly C. neoformans disseminates to the mouse brain. 164
We focused on the intranasal model since this procedure is non-invasive, 165 requiring only brief anesthesia and no surgery. We found that 3 h post infection with 166 5x10 5 yeast inoculum, the fungal burden in the brain was in the order of hundreds of 167 CFU for most animals ( Fig. 2A) . The surprising finding that yeasts were detectable in 168 the brain within hours after IN inoculation prompted us to perform additional controls. 169
For one experiment we rinsed the brains (to remove possible yeast contaminations from 170 the exterior surface of the brain during necropsy) but we got comparable results to the 171 first experiment (data pooled from both experiments is shown). We also culled one non-172 infected mouse ("sentinel") at the end of the experiment to measure eventual 173 contamination of tools and materials during necropsy that could cross-contaminate the 174 media plates. We recovered no CFU from the sentinel mouse which gave us 175 confidence that the fungal burden we detect are result from brain infection and not 176 accidental contamination (data not shown). To investigate if early dissemination could 177 occur at lower doses we infected animals with 5x10 3 CFU (at this dose C. neoformans 178 causes 80% mortality at 40 days). We still observed quick dissemination to the brain, 179
indicating that this was not a consequence of exposure to overwhelmingly high numbers 180
of yeasts. Finally, we observed quick dissemination to the brain with strain H99O, a 181 strain closely related to the original H99 clinical isolate of C. neoformans, as well as the 182 R265 strain of C. gattti, the strain associated with the Vancouver outbreak ( Fig. 2B) . It is 183 possible that the detected yeast burden is arrested in the small capillaries (23-26), or in 184 the post-capillary venules (27) and has not yet invaded the brain parenchyma. However, 185 this is consistent with invasion of the brain since upon arrest in capillaries, C. 186 neoformans quickly crosses endothelial barriers (24) and possibly the blood brain-187 barrier. These experiments show that after intranasal infection, pathogenic strains of C. 188 neoformans and C. gattii disseminate to the mouse brain in as little as 3 h. 189
To confirm presence of yeast in the brain, we performed immunofluorescence in 190 skulls of infected mice, using a monoclonal antibody against C. neoformans capsular 191 GXM (21). In agreement with the results of CFU quantification, we detected yeast cells 192 (positive immunostaining and with typical morphology) in the mouse brain at 24 h post 193 infection ( Fig. 3A, inset) . We wondered if it was possible for C. neoformans could 194 provoke damage to the nose mucosa and from there access the brain through 195 damaging the olfactory mucosa and using the olfactory nerves to traverse the cribriform 196 plate (as shown for bacterial pathogens (28, 29) or if after damage the mucosa access 197 the host bloodstream for dissemination. We reasoned that if dissemination occurred 198 through the olfactory system, then the olfactory bulb would contain the majority of 199 yeasts, compared to the remainder of the brain. We infected mice and separated their 200 olfactory bulb from the remainder of the brain (Fig. 3B ). We found that the olfactory bulb 201 contains similar amounts of yeasts to the remainder of the brain, despite its small size 202 compared to the rest of the brain. 203
To investigate the interaction of C. neoformans with the nose, and possible 204 damage to the nose mucosa that could facilitate dissemination, we performed 205 histological studies using a combination of histology, immunofluorescence, Grocott-206
Merwald-Silver, and mucicarmine ( Fig. 4) . We found yeasts scattered throughout the 207 entire upper respiratory tract, particularly in the turbinates of the nose, and some yeasts 208 close to the cribriform plate ( Fig.4A-C) , as well as in the ear canals of mice ( Fig. 4D) . 209
Yeasts were abundant in airways, surrounded with a material that is likely mucus 210 secretions from the host, but that stained abundantly with capsular GXM antibody, 211 indicating a component of secreted polysaccharide in the airways (Fig. 4B) . Budding 212 forms rested on the respiratory epithelium cilia and olfactory epithelium layer, and yeast 213 numbers increased in number from 3 h to the 24 h post infection and increased 214 immunostaining of GXM (Fig. 4F ). We noted at 24 h post infection there were rare 215 enlarged yeast cells within the nose turbinates and ears ( Fig. 4C-G 
Discussion: 226
Animal models of infection are critical tools for understanding the pathogenesis of 227 infectious diseases. In the cryptococcal field, mice are the most commonly used 228 mammalian species to study pathogenesis and immune responses. We compared the 229 kinetics of brain dissemination in three models of cryptococcal infection that are 230 commonly used: IV, IN and IT. We were particularly interested in IN infection since this 231 approach has become increasingly popular in the field. We found early dissemination to 232 the brain and colonization of upper respiratory tract by C. neoformans and C. gattii. Our 233 data suggest early invasion of the brain and a colonization of the nose by both 234 cryptococcal species in mouse models. 235 Quick dissemination to the brain observed in our mouse model is compatible with 236 an hematogenous route of dissemination. Recent work has proposed that escape from 237 the lungs occurs due to phagocyte drainage through the lymphatic system (34). It has 238 not yet been shown how C. neoformans escapes from the lymph nodes into the 239 bloodstream (35-37), but this will likely be elucidated in the future. We detected no 240 yeasts in the circulating blood of mice, which raises a question of how the bloodstream 241 is so quickly invaded and quickly cleared. Other groups observed that in IV infection 242 fungi are cleared from the bloodstream in hours or the day after infection (27, 35), with 243 fungemia only resurfacing very late in the infection. These observations, together with 244 ours, imply that yeast transit time in blood is very short (25). The short transit time is 245 seemingly due to arrest of yeasts within small capillaries, as can occur in the ears of 246 mice (24) and in the lumen of leptomeningeal capillaries (24, 27). Yeasts arrested in 247 capillaries would not be detected by our methodology. In contrast, others found that 248 blood contains both free yeast cells as well as yeast cells in the buffy coat, i.e., engulfed 249 by phagocytic immune cells, for up to 20 days post-inoculation. Depletion of 250 mononuclear phagocytes decreases the number of yeasts brain detected in the brain 251 (23, 26, 34, 35). Regardless of the short transit time, there is sufficient experimental 252 evidence to support that dissemination to the brain occurs via the hematogenous route, 253 by direct crossing of the blood brain barrier by free yeast cells, and by indirect carriage 254 within host mononuclear phagocytes, the Trojan-horse transport. 255
In models of intravenous (IV) inoculation, yeast dissemination to the brain occurs 256 as early as 90 min after inoculation (36) (38). The speed of C. neoformans 257 dissemination to the brain was attributed to the intravenous inoculation model that can 258 simulate fungemia, an event that occurs very late in natural infections. Our findings 259 confirm that IV infection disseminated more efficiently to the brain, but all infection 260 routes lead to presence of viable yeasts within the brain as early as 3 h post infection. 261
Others had detected yeasts in the brain after intranasal infection as early as 3 d (39). 262
We did not experimentally confirm the same quick dissemination to the brain occurs 263 with intratracheal infection, but we expect the intratracheal route of infection to be 264 similar to the intranasal route for 2 reasons: i) at day 3 the fungal burden was similar for 265 both routes; ii) due to sneezing (and possibly coughing reflexes), inoculation into the 266 trachea would quickly spread C. neoformans throughout the entire upper respiratory 267 tract. It is our view that once the lungs are infected, the entire upper respiratory tract 268 becomes infected. Therefore, we believe that brain dissemination occurs very rapidly fungus Mucor invades the facial blood vessels from the sinus to reach the eye, the 280 cranial nerves and the brain. In the case of C. neoformans, the possibility of brain 281 dissemination through the nose has been pursued previously (41). In mice, yeast cells 282 were observed along the olfactory nerve and the meninges starting at day 3 post 283 intranasal instillation (41). Our study differs from this previous study because we 284 focused on the earliest stages of infection and found no evidence of an upward invasion 285 of the brain. We observed no signs of mucosal damage and no inflammation in the nose 286 cavity, despite the presence of abundant yeasts and secreted GXM. In interpreting 287 these results, we relied on the terminology of the damage-response framework that 288 defines infection as the acquisition of the microbe by the host and colonization as a 289 state where the damage resulting from the host-microbe interaction is insufficient to 290 affect homeostasis (42). From this perspective, the lack of visible damage suggests that 291 infection leads simply to nasal colonization and not overt disease. Given the lack of 292 damage and inflammatory infiltrate our findings do not support the notion that invasion Serological studies indicate that humans are exposed to C. neoformans at an 319 early age (7), and that C. neoformans can reside in the lungs in a latent form (9). Non- However this is a surprising finding since animal disease has so far recapitulated 337 human disease (13, 15, 65) . 338
In summary, our study shows the presence of the colonization of the upper 339 respiratory tract of C. neoformans in mouse models with rapid dissemination to the 340 brain, independently of the infection route. The rapid appearance of yeast cells in 341 different body compartments where they initiate local immune responses suggests 342 caution in associating a particular systemic response with a specific tissue. At the very 343 least, our findings suggest the need to revisit long held views on cryptococcal 344 pathogenesis in animal models of infection using the most modern cellular and 345 histology. Yeast cells could be observed in the olfactory bulb of the brain of mice at 24 619 hpi (top panel, arrows). Non-infected animals were processed under the same 620
